Aprea Therapeutics, Inc. (APRE)
0.8065
-0.01
(-1.65%)
USD |
NASDAQ |
Sep 03, 16:00
0.8065
0.00 (0.00%)
After-Hours: 17:01
Aprea Therapeutics Cash and Short Term Investments (Quarterly) : 41.23M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 41.23M |
| March 31, 2026 | 46.47M |
| December 31, 2025 | 14.60M |
| September 30, 2025 | 13.72M |
| June 30, 2025 | 16.53M |
| March 31, 2025 | 19.28M |
| December 31, 2024 | 22.85M |
| September 30, 2024 | 26.25M |
| June 30, 2024 | 28.69M |
| March 31, 2024 | 32.37M |
| December 31, 2023 | 21.61M |
| September 30, 2023 | 25.35M |
| June 30, 2023 | 27.69M |
| March 31, 2023 | 31.00M |
| Date | Value |
|---|---|
| December 31, 2022 | 28.79M |
| September 30, 2022 | 33.11M |
| June 30, 2022 | 39.06M |
| March 31, 2022 | 47.65M |
| December 31, 2021 | 53.08M |
| September 30, 2021 | 61.43M |
| June 30, 2021 | 69.80M |
| March 31, 2021 | 77.62M |
| December 31, 2020 | 89.02M |
| September 30, 2020 | 101.15M |
| June 30, 2020 | 112.86M |
| March 31, 2020 | 122.51M |
| December 31, 2019 | 130.09M |
| September 30, 2019 | 52.33M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Zymeworks, Inc. | 270.70M |
| Rhythm Pharmaceuticals, Inc. | 330.90M |
| Onconetix, Inc. | 5.942M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |